Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Michael Andrew Jenike, M.D.


This page shows the publications co-authored by Michael Jenike and Nathaniel Alpert.
Connection Strength

  1. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmacology. 2002 Nov; 27(5):782-91.
    View in: PubMed
    Score: 0.065
  2. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biol Psychiatry. 1997 Sep 15; 42(6):446-52.
    View in: PubMed
    Score: 0.045
  3. Probing striatal function in obsessive-compulsive disorder: a PET study of implicit sequence learning. J Neuropsychiatry Clin Neurosci. 1997; 9(4):568-73.
    View in: PubMed
    Score: 0.043
  4. A positron emission tomographic study of simple phobic symptom provocation. Arch Gen Psychiatry. 1995 Jan; 52(1):20-8.
    View in: PubMed
    Score: 0.038
  5. Cerebral metabolic correlates as potential predictors of response to anterior cingulotomy for obsessive compulsive disorder. Biol Psychiatry. 2001 Nov 01; 50(9):659-67.
    View in: PubMed
    Score: 0.015
  6. A symptom provocation study of posttraumatic stress disorder using positron emission tomography and script-driven imagery. Arch Gen Psychiatry. 1996 May; 53(5):380-7.
    View in: PubMed
    Score: 0.010
  7. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Arch Gen Psychiatry. 1994 Jan; 51(1):62-70.
    View in: PubMed
    Score: 0.009
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.